Par Pharmaceutical Companies Inc (PRX) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE RAM RIDGE ROAD
CHESTNUT RIDGE, NY 10977
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

6/30/2015
MRQ
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 244,440,000133,621,000
Cash and cash equivalents 244,440,000130,080,000
Short-term investments  3,541,000
Receivables 158,732,000143,279,000
Inventory, net of allowances, customer advances and progress billings 154,687,000117,307,000
Inventory 154,687,000117,307,000
Income taxes receivable1,458,000
Other undisclosed current assets 95,191,00069,912,000
Total current assets: 653,050,000465,577,000
Noncurrent Assets
Property, plant and equipment 217,314,000127,276,000
Intangible assets, net (including goodwill) 2,052,861,0001,942,300,000
Goodwill 1,012,108,000849,652,000
Intangible assets, net (excluding goodwill) 1,040,753,0001,092,648,000
Other noncurrent assets 83,909,00096,342,000
Total noncurrent assets: 2,354,084,0002,165,918,000
TOTAL ASSETS: 3,007,134,0002,631,495,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 167,441,00066,867,000
Interest and dividends payable 7,529,000 
Employee-related liabilities 32,246,00020,700,000
Accounts payable 79,987,00031,181,000
Accrued liabilities 47,679,00014,986,000
Debt 14,503,00021,462,000
Estimated litigation liability  41,367,000
Other undisclosed current liabilities 95,860,000129,275,000
Total current liabilities: 277,804,000258,971,000
Noncurrent Liabilities
Long-term debt and lease obligation 1,904,069,0001,516,057,000
Long-term debt, excluding current maturities 1,904,069,0001,516,057,000
Liabilities, other than long-term debt 247,191,000288,783,000
Deferred tax liabilities, net 247,191,000288,783,000
Other undisclosed noncurrent liabilities (2,134,256,000)(1,784,518,000)
Total noncurrent liabilities: 17,004,00020,322,000
Total liabilities: 294,808,000279,293,000
Equity
Equity, attributable to parent 561,066,000547,362,000
Additional paid in capital 808,647,000686,577,000
Accumulated other comprehensive loss (3,648,000)(799,000)
Accumulated deficit (243,933,000)(138,416,000)
Total equity: 561,066,000547,362,000
Other undisclosed liabilities and equity 2,151,260,0001,804,840,000
TOTAL LIABILITIES AND EQUITY: 3,007,134,0002,631,495,000

Income Statement (P&L) (USD)

6/30/2015
TTM
12/31/2014
12/31/2013
Other undisclosed net loss attributable to parent  (105,871,000)
Net loss available to common stockholders, diluted:  (105,871,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: